Mirae Asset Global ETFs Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$243K	Buy	+37,987	New	+$243K	﹤0.01%	2179
2024 Q3	–	Sell	-26,032	Closed	-$49.5K	–	3074
2024 Q2	$49.5K	Buy	+26,032	New	+$49.5K	﹤0.01%	2791